Skip to content

Bacterial Control in Partial Thickness Burns Using Silver-containing Wound Dressings

Bacterial Control in Partial Thickness Burns Using Silver-containing Wound Dressings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00343824
Enrollment
100
Registered
2006-06-23
Start date
2006-11-01
Completion date
2010-07-31
Last updated
2022-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Wounds - Partial Thickness (2nd Degree)

Keywords

Burn wounds - Silver Dressings - Bacterial Control

Brief summary

This study is to compare the treatment with two different silver-containing wound dressings: aquacel AG hydrofiber versus acticoat burn dressing.

Interventions

PROCEDUREaquacel AG hydrofiber versus acticoat burn dressing

Aquacel AG hydrofiber versus acticoat burn dressing will be compared.

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
No

Inclusion criteria

* Burn wounds with flux values, measured by Laser Doppler Imaging, corresponding with expected healing time between 7 and 21 days, flux values between 200 and 1000 (red-pink or pink-yellow-green colour) * Wounds treated with a hydrocolloid paste prior to LDI * Possibility to follow the complete treatment schedule until wound healing and participation on complete follow-up schedule * Informed consent * Partial thickness burns with TBSE \< 40%

Exclusion criteria

* Mean flux values \< 200 or \> 1000 * TBSA \> 40% * Impossibility to debride necrotic skin prior to LDI measurement * Wounds treated with any topical ointments or dressings other than hydrocolloid prior to LDI * Not following the complete treatment schedule or missing some evaluations during the follow-up period * Patient has any condition that seriously compromises the patient's ability to complete the study * Patient has participated in another study using an investigational drug within the previous 30 days * Patient has one or more medical condition(s)that in the opinion of the investigator would make the patient an inappropriate candidate for this study * The plastic surgeon decides that surgery is necessary due to unusual circumstances * Patient wish to decline from the study * No informed consent * Full thickness burns

Design outcomes

Primary

MeasureTime frame
Evaluation of the efficacy of both wound dressings in controlling wound bioburden over a period of 21 daysOver a period of 21 days

Secondary

MeasureTime frame
Percentage of genetically-acquired resistance to silverOnce after wound closure.
Healing time comparisonEvery 3 days until healing
Comparison of blood silver levelsEvery week until woundhealing. In folluw-up: at 3, 6 and 12 months
Cost-effectivenessOnce after wound closure.
Health related quality of lifeAt 1, 3, 6 and 12 months after wound closure
Scar quality assessmentAt 1, 3, 6 and 12 months after wound closure

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026